InvestorsHub Logo
Followers 167
Posts 35823
Boards Moderated 3
Alias Born 10/20/2019

Re: budfoxfun post# 40

Monday, 07/26/2021 10:14:22 AM

Monday, July 26, 2021 10:14:22 AM

Post# of 396
Looks like Chardan already has a diversified portfolio and chose to add $FEMY to it family.

This transaction further solidifies Chardan's dedication to ESG and healthcare companies with novel and differentiated platforms. Since 2020, Chardan has acted as book runner or lead placement agent in 32 transactions including for healthcare companies: 4D Pharma plc (PIPE), Forge Biologics (Private offering) Forte Biosciences (FO), GenSight Biologics (PIPE), Immunome (IPO), Immunovant (FO), MeiraGTx (FO), NeuBase Therapeutics (FO), and Renovacor (announced PIPE).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FEMY News